PRODUCT LITERATURE

ORAL SUPPLEMENTATION WITH FERROUS SULFATE BUT NOT WITH NONIONIC IRON POLYMALTOSE COMPLEX lNCREASES THE SUSCEPTIBILITY OF PLASMA LIPOPROTEINS TO OXIDATION

---

Iron deficiency anemia is customarily treated by iron supplementation. However, iron can act as a catalyst of lipid peroxidation in vitro, and high intake of heme iron has been associated with an increased risk of myocardial infarction in some, but not in all
epidemiologic studies. We carried out a 6-month trial of the effects of supplementation of men (n=48) with low iron stores with ferrous sulfate (180 mg of iron per day), iron polymaltose complex (200 mg of iron per day) or placebo

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Feritrin

Specific Detail Info

Nutrition Research, Vol. 19, No. 8, pp. 1121-1132,1999

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment